Avinger (NASDAQ:AVGR) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Avinger (NASDAQ:AVGR) in a report published on Thursday morning. The firm issued a hold rating on the medical device company’s stock.

Avinger Price Performance

Shares of NASDAQ AVGR opened at $0.47 on Thursday. Avinger has a fifty-two week low of $0.36 and a fifty-two week high of $4.37. The stock has a market capitalization of $1.57 million, a price-to-earnings ratio of -0.04 and a beta of 1.09. The business has a 50-day moving average of $0.49 and a 200-day moving average of $0.71.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.